ELSALYS BIOTECH Employee Directory
Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees
ElsaLys Biotech is a small- to mid-sized specialty pharmaceutical company headquartered in Lyon, in the Auvergne-Rhône-Alpes region of France. It operates within the Mediolanum Farmaceutici Spa group and focuses on developing innovative medicines for life-threatening and rare diseases in the hematology-oncology space. Founded in 2013, the firm sits within the Lyon Biopole cluster and pursues an immunotherapy-focused portfolio aimed at niche drugs that address unmet medical needs. Its growth strategy has involved strategic acquisitions and targeted development, including securing worldwide development and commercialization rights for Leukotac from Jazz Pharmaceuticals in 2017. This asset-based approach reflects its emphasis on building a portfolio within the specialty pharmaceutical field to provide essential therapies that meet public health needs.